NantKwest

NantKwest is a clinical-stage immunotherapy company focused on harnessing the immune system to treat disease

NantKwest is a biotechnology company, engages in developing immunotherapeutic agents for various clinical conditions in the United States. The company’s product candidates include activated natural killer candidates for the treatment of virally-induced cancers, such as human papilloma virus induced cervical, and head and neck cancers; ebola; and serious viral, fungal, and bacterial infections, as well as that is in Phase II clinical trials for the treatment of polyoma virus induced merkel cell carcinoma.